The objective of this clinical trial is to know the usability and efficacy of SMARTCLOTH for better control and adherence to the dietary patterns recommended to patients with diabetes, both the portion diet system (more common for cases of Diabetes Mellitus type 1 -DM1-), and the plate method (more recommended in cases of Diabetes Mellitus type 2-DM2-). The main questions are: * Does the use of SMARTCLOTH improve glycemic control in patients with diabetes mellitus? * Do patients with diabetes mellitus find SMARTCLOTH useful in their daily lives? The researchers will compare changes over 3 months in variables related to glycemic control in two groups, one using SMARTCLOTH (intervention group) and the other following standard recommendations (control group). To do so, participants will have to: * Use SMARTCLOTH for 3 months or follow the recommendations they receive from their referring health professionals. * Come back after three months for a check-up of the chosen variables. * The experimental group should contact the investigators in case the hardware has any problems.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
90
The intervention consists of using SMARTCLOTH. This device makes it possible to monitor dietary intake throughout the day and record it in a database that, through a website, allows to track it. SMARTCLOTH is a digital tablecloth consisting of a scale, several buttons and a screen. The device allows weighing the food to be consumed and recording its nutritional value (macronutrients in grams, macronutrient servings and kilocalories). The latter is achieved because SMARTCLOTH allows the patient to select to which food group the food being weighed belongs, increasing the accuracy of the nutritional estimation.
Ugc Centro
Córdoba, Andalusia, Spain
Ugc Lucano
Córdoba, Andalusia, Spain
Ugc Aeropuerto
Córdoba, Andalusia, Spain
Ugc Fuensanta
Córdoba, Andalusia, Spain
Ugc La Carlota
Córdoba, Andalusia, Spain
glycated hemoglobin
The test shows an average of the blood sugar level over the past 90 days and represents a percentage. The test can also be used to diagnose diabetes
Time frame: From enrollment to the end of treatment at 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.